Literature DB >> 16570078

Chromatin signatures of pluripotent cell lines.

Véronique Azuara1, Pascale Perry, Stephan Sauer, Mikhail Spivakov, Helle F Jørgensen, Rosalind M John, Mina Gouti, Miguel Casanova, Gary Warnes, Matthias Merkenschlager, Amanda G Fisher.   

Abstract

Epigenetic genome modifications are thought to be important for specifying the lineage and developmental stage of cells within a multicellular organism. Here, we show that the epigenetic profile of pluripotent embryonic stem cells (ES) is distinct from that of embryonic carcinoma cells, haematopoietic stem cells (HSC) and their differentiated progeny. Silent, lineage-specific genes replicated earlier in pluripotent cells than in tissue-specific stem cells or differentiated cells and had unexpectedly high levels of acetylated H3K9 and methylated H3K4. Unusually, in ES cells these markers of open chromatin were also combined with H3K27 trimethylation at some non-expressed genes. Thus, pluripotency of ES cells is characterized by a specific epigenetic profile where lineage-specific genes may be accessible but, if so, carry repressive H3K27 trimethylation modifications. H3K27 methylation is functionally important for preventing expression of these genes in ES cells as premature expression occurs in embryonic ectoderm development (Eed)-deficient ES cells. Our data suggest that lineage-specific genes are primed for expression in ES cells but are held in check by opposing chromatin modifications.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16570078     DOI: 10.1038/ncb1403

Source DB:  PubMed          Journal:  Nat Cell Biol        ISSN: 1465-7392            Impact factor:   28.824


  576 in total

1.  Distinct epigenomic landscapes of pluripotent and lineage-committed human cells.

Authors:  R David Hawkins; Gary C Hon; Leonard K Lee; Queminh Ngo; Ryan Lister; Mattia Pelizzola; Lee E Edsall; Samantha Kuan; Ying Luu; Sarit Klugman; Jessica Antosiewicz-Bourget; Zhen Ye; Celso Espinoza; Saurabh Agarwahl; Li Shen; Victor Ruotti; Wei Wang; Ron Stewart; James A Thomson; Joseph R Ecker; Bing Ren
Journal:  Cell Stem Cell       Date:  2010-05-07       Impact factor: 24.633

Review 2.  The roles and regulation of Polycomb complexes in neural development.

Authors:  Matthew Corley; Kristen L Kroll
Journal:  Cell Tissue Res       Date:  2014-11-01       Impact factor: 5.249

3.  Temporal uncoupling of the DNA methylome and transcriptional repression during embryogenesis.

Authors:  Ozren Bogdanovic; Steven W Long; Simon J van Heeringen; Arie B Brinkman; Jose Luis Gómez-Skarmeta; Hendrik G Stunnenberg; Peter L Jones; Gert Jan C Veenstra
Journal:  Genome Res       Date:  2011-06-02       Impact factor: 9.043

Review 4.  Smooth muscle cell phenotypic switching in atherosclerosis.

Authors:  Delphine Gomez; Gary K Owens
Journal:  Cardiovasc Res       Date:  2012-03-08       Impact factor: 10.787

5.  Epigenetic mechanisms involved in developmental nutritional programming.

Authors:  Anne Gabory; Linda Attig; Claudine Junien
Journal:  World J Diabetes       Date:  2011-10-15

Review 6.  Epigenetic landscape of pluripotent stem cells.

Authors:  Ji Woong Han; Young-sup Yoon
Journal:  Antioxid Redox Signal       Date:  2012-01-11       Impact factor: 8.401

Review 7.  Histone methylation in myelodysplastic syndromes.

Authors:  Yue Wei; Irene Gañán-Gómez; Sophie Salazar-Dimicoli; Sara L McCay; Guillermo Garcia-Manero
Journal:  Epigenomics       Date:  2011-04       Impact factor: 4.778

Review 8.  Epigenetic control on cell fate choice in neural stem cells.

Authors:  Xiao-Ling Hu; Yuping Wang; Qin Shen
Journal:  Protein Cell       Date:  2012-05-02       Impact factor: 14.870

Review 9.  A decade of exploring the cancer epigenome - biological and translational implications.

Authors:  Stephen B Baylin; Peter A Jones
Journal:  Nat Rev Cancer       Date:  2011-09-23       Impact factor: 60.716

10.  EZH2-specific microRNA-98 inhibits human ovarian cancer stem cell proliferation via regulating the pRb-E2F pathway.

Authors:  Te Liu; Lengchen Hou; Yongyi Huang
Journal:  Tumour Biol       Date:  2014-04-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.